Sur vs Tonga: New cases tested for RR-/MDR-TB

Sur
97.0%
in 2024
Tonga
100.0%
in 2023
Sur rank
1st
Tonga rank
1st

New cases tested for RR-/MDR-TB over time

  • Sur
  • Tonga
020406080100200520142024

How they compare

Tonga currently reports 100.0% against 97.0% in Sur, a difference of 3.0%.

The two have swapped places 3 times across 14 shared years of data; in 2010 it was Sur ahead.

Sur ranks 1st and Tonga ranks 1st of 1 regions.

Across the 2 decades both report, Sur averaged higher in 1 and Tonga in 1.

Head to head by decade

Decade Sur Tonga Difference Ahead
2010s 62.2% 30.0% 32.2% Sur
2020s 97.2% 100.0% 2.8% Tonga

Averages of every year both report within each decade.

Frequently asked questions

Which has higher new cases tested for rr-/mdr-tb, Sur or Tonga?
Tonga, at 100.0% against 97.0% in Sur as of 2023.
What is the difference in new cases tested for rr-/mdr-tb between Sur and Tonga?
3.0%, with Tonga ahead.
How many years of comparable data are there for Sur and Tonga?
14 years are reported by both, from 2010 to 2023.
How do Sur and Tonga rank globally for new cases tested for rr-/mdr-tb?
Sur ranks 1st and Tonga ranks 1st of 1 regions.
Where does this data come from?
World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Sur vs Tonga: New cases tested for RR-/MDR-TB. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 24 August 2026, from https://health.statizoid.com/compare/new-cases-tested-for-rr-mdr-tb-percent/sur/tonga/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/new-cases-tested-for-rr-mdr-tb-percent/sur/tonga/">Sur vs Tonga: New cases tested for RR-/MDR-TB</a> — Statizoid

About this data

Indicator
New cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
204 places, 3,368 data points, 2005–2024
Last refreshed